Open Access
Hemostatic agents for access tract in tubeless percutaneous nephrolithotomy: Is it worth?
Author(s) -
Francisco Sepúlveda,
Alfredo Aliaga,
Daniela Fleck,
Mario I. Fernández,
Alejandro Mercado,
Roberto Vilches,
Francisco de Borja Varona Moya,
Rodrigo Ledezma,
Diego Reyes,
Fernando Marchant
Publication year - 2016
Publication title -
urology annals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.355
H-Index - 20
eISSN - 0974-7834
pISSN - 0974-7796
DOI - 10.4103/0974-7796.163796
Subject(s) - percutaneous nephrolithotomy , medicine , percutaneous , lithotomy position , surgery , alternative medicine , pathology
The role of hemostatic agents as an adjunct for closure of the nephrostomy tract in tubeless percutaneous surgery (tubeless percutaneous nephrolithotomy [tPNL]) has been previously evaluated, observing a potential benefit in terms of reduced bleeding and urinary leakage. We assessed the rate of postoperative complications after the use of hemostatic agents for sealing the nephrostomy tract in patients undergoing tPNL at our institution.